Some analysts say that the new CEO at Amgen ($AMGN)--Bob Bradway (photo)--will need to pull off more licensing and buyout deals if he wants to earn a good reputation for an up-an-coming pipeline effort. Report
Some analysts say that the new CEO at Amgen ($AMGN)--Bob Bradway (photo)--will need to pull off more licensing and buyout deals if he wants to earn a good reputation for an up-an-coming pipeline effort. Report